Highnoon Laboratories Limited (PSX:HINOON)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
981.47
+25.72 (2.69%)
At close: Jun 27, 2025
35.37%
Market Cap 52.00B
Revenue (ttm) 25.51B
Net Income (ttm) 3.53B
Shares Out 52.98M
EPS (ttm) 66.70
PE Ratio 14.71
Forward PE n/a
Dividend 40.00 (4.08%)
Ex-Dividend Date Apr 18, 2025
Volume 75,427
Average Volume 24,133
Open 959.20
Previous Close 955.75
Day's Range 932.00 - 992.00
52-Week Range 626.96 - 1,000.00
Beta 0.12
RSI 55.82
Earnings Date Aug 26, 2025

About Highnoon Laboratories

Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products. It offers products in various therapeutic areas, including allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynaecology, paediatrics, allergy, respiratory, and urology; and generic products under various brands. The company operates in Pakistan, Afghanistan, the United Arab Emirates, France, Kenya, Iraq, Cambodia, Tanzania, Dubai, Sudan, an... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1984
Employees 2,376
Stock Exchange Pakistan Stock Exchange
Ticker Symbol HINOON
Full Company Profile

Financial Performance

In 2024, Highnoon Laboratories's revenue was 24.63 billion, an increase of 24.60% compared to the previous year's 19.77 billion. Earnings were 3.39 billion, an increase of 38.44%.

Financial Statements

News

There is no news available yet.